Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Carasent AB (publ)APXZF 73 Earnings per Share (Diluted) is $0.07 as of Jun. 2026. GuruFocus rates APXZF with a GF Score™ of 73/100 and a GF Value™ of $0.16. The stock has 5 warning signs investors should review. Among 506 Healthcare Providers & Services companies, Carasent AB (publ) ranks worse than 82.81% on this metric.
Carasent AB (publ)'s EPS (Basic) for the
three
months ended in Jun. 2026 was $-0.00.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was $0.07.
During the past 3 years, the average EPS without NRIGrowth Rate was -17.90% per year.
During the past 13 years, Carasent AB (publ)'s highest 3-Year average EPS without NRI Growth Rate was 124.70% per year. The lowest was -536.20% per year. And the median was -1.60% per year.
Carasent AB (publ) (OTCPK:APXZF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Carasent AB (publ) Earnings per Share (Diluted) Related Terms
Carasent AB (publ) Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Carasent AB (publ)'s Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carasent AB (publ) Earnings per Share (Diluted) Chart
APXZF vs VEEV, BTSG, HQY: Earnings per Share (Diluted) Comparison
For the Health Information Services subindustry, Carasent AB (publ)'s PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carasent AB (publ) PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Carasent AB (publ)'s PE Ratio distribution charts can be found below:
* The bar in red indicates where Carasent AB (publ)'s PE Ratio falls into.
Carasent AB (publ) Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Carasent AB (publ)'s Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.07
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $0.07 mean?
Carasent AB (publ) (APXZF) has a Earnings per Share (Diluted) of $0.07 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Carasent AB (publ) and its competitors. According to the industry distribution chart, Carasent AB (publ) ranks #419 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 82.8%.
Is Carasent AB (publ)'s Earnings per Share (Diluted) too high?
Carasent AB (publ)'s current Earnings per Share (Diluted) is $0.07. The Healthcare Providers & Services industry median Earnings per Share (Diluted) is 11.00. Carasent AB (publ)'s value of $0.07 is 99.4% below this industry median. Based on the distribution chart, Carasent AB (publ) ranks #419 out of 506 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Carasent AB (publ) has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Carasent AB (publ)'s Earnings per Share (Diluted) compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Carasent AB (publ) ranks #419 out of 506 companies for Earnings per Share (Diluted). This places Carasent AB (publ) in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.00. Carasent AB (publ)'s value of $0.07 is 99.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.00, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carasent AB (publ)'s current Earnings per Share (Diluted) of $0.07 is 99.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Carasent AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carasent AB (publ)'s current Earnings per Share (Diluted) is $0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carasent AB (publ) stock overvalued right now?
Carasent AB (publ) (APXZF) has a current Earnings per Share (Diluted) of $0.07. The stock's GF Value™ is $0.16, compared to a current price of $0.15 — trading 6.3% below its estimated fair value. The current Earnings per Share (Diluted) is $0.07 and 99.4% below the Healthcare Providers & Services industry median of 11.00. Carasent AB (publ)'s overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Carasent AB (publ) (APXZF), the current Earnings per Share (Diluted) is $0.07 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carasent AB (publ) (APXZF) Overvalued in 2026?
Based on GuruFocus' analysis, Carasent AB (publ) stock appears to be undervalued.
The current stock price of $0.15 is trading 6.3% below its estimated GF Value™ of $0.16.
Key valuation signals for APXZF:
Earnings per Share (Diluted): $0.07
GF Value™: $0.16 vs. price of $0.15 (6.3% below fair value)
Industry Position: 99.4% below the Healthcare Providers & Services median (#419 of 506)
No single metric tells the full story. See the APXZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carasent AB (publ) Formerly Carasent AB is a comprehensive provider of cloudbased EHR solutions and platform services for various organizations within the healthcare sector. With Webdoc as the main product, the group offers a broad ecosystem of services, including solutions for patient communication and business intelligence. Geographically, the company operates in the Nordic region and Germany. It derives maximum revenue from Nordic Region. The solutions provides by the group are: Webdoc; Metodika; Medrave; HPI plustoo; Ad Curis; Ad Opus; Webcur; Data-AL; and Data-Cur.
73GF Score
Get the complete analysis for APXZF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
APXZF has been successfully added to your 
